Skip to main content
. 2022 Oct;63(10):1515–1522. doi: 10.2967/jnumed.121.263442

TABLE 3.

Differences in Longitudinal Data of d-ROMs and Anti-ROMsS/F Between HYPO and rhTSH Groups

HYPO rhTSH
Variable Baseline 1 wk 3 mo P Baseline 1 wk 3 mo P
d-ROMs 399.75 ± 86.51 (368.02–431.48) 333.46 ± 71.07 (307.39–359.53) 402.93 ± 72.60* (375.82–430.04) <0.0001 374.22 ± 75.56 (345.72–402.72) 355.20 ± 93.50 (319.93–390.47) 363.62 ± 66.84* (338.20–389.04) 0.29
Anti-ROMsF 209.15 ± 50.53 (190.61–227.68) 215.13 ± 47.25 (197.80–232.46) 212.13 ± 52.46 (192.89–231.37) 0.83 211.49 ± 35.75 (197.63–225.36 219.53 ± 36.46 (205.39–233.67) 202.81 ± 30.95 (191.46–214.16) 0.07
Anti-ROMsS 727.15 ± 121.06 (682.75–771.55) 731.30 ± 172.46 (668.04–794.56) 727.31 ± 134.85 (677.85–776.77) 0.99 681.79 ± 116.81 (636.50–727.09) 720.57 ± 96.55 (683.13–758.01) 665.52 ± 105.12 (626.96–704.08) 0.09
*

HYPO vs. rhTSH: d-ROMs: P (3 mo vs. 3 mo) = 0.03.

Post hoc analysis: HYPO. d-ROMs: P (baseline vs. 1 wk) = 0.0001; P (1 wk vs. 3 mo) < 0.0001. Normal values are <300 CARR U for d-ROMs, >200 μEq/L for anti-ROMsF, and >1,000 μEq/L for anti-ROMsS. Data are mean ± SD and 95%CI.